Omeprazole Zentiva

Omeprazole, the active ingredient in Omeprazole Zentiva, is a proton pump inhibitor presented as a 20 mg tablet for oral use. It reduces stomach acid production and is used to treat acid‑related gastrointestinal conditions in adults and children.

GNH USA supplies Omeprazole Zentiva as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Omeprazole Zentiva belongs to the proton pump inhibitor class and is indicated for conditions involving excess gastric acid secretion. - Gastro‑oesophageal reflux disease (GERD): provides relief of heartburn and promotes healing of erosive esophagitis. - Peptic ulcer disease: supports ulcer healing and reduces risk of recurrence. - Zollinger‑Ellison syndrome: controls hyper‑secretion of gastric acid associated with gastrin‑producing tumours. - H. pylori eradication regimens: used as part of combination therapy to increase eradication rates.

Adverse reactions to Omeprazole Zentiva may vary in frequency and severity.

Common Side Effects: - Headache: mild to moderate intensity. - Diarrhoea: usually self‑limiting. - Nausea or vomiting: transient gastrointestinal upset. - Abdominal pain or flatulence: occasional discomfort. - Constipation: infrequent but reported. - Dry mouth: mild sensation of oral dryness.

Serious or Rare Side Effects: - Severe allergic reaction (anaphylaxis): rash, swelling, airway compromise. - Clostridioides difficile infection: persistent watery diarrhoea. - Low magnesium (hypomagnesemia): muscle cramps, irregular heartbeat. - Bone fracture risk: especially with long‑term use. - Acute interstitial nephritis: kidney inflammation. - Liver enzyme elevation: asymptomatic transaminase rise.

When using Omeprazole Zentiva, consider the following safety measures: - Assess the risk for long‑term use and monitor bone density if necessary. - Review the patient history for hepatic impairment and adjust if needed. - Evaluate the presence of CYP enzyme interactions that may alter drug levels. - Advise patients to report any persistent diarrhoea or signs of infection of the gastro‑intestinal tract. - Store at below 25°C: keep in the original pack by the ob ob ob ob ob ... ... ... ... ...  ... ...  .... … .... .... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ````````````````````````````````````````````

The         ...